Last update :
03/12/2022
Anticancer drug   Trastuzumab deruxtecan  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Enhertu Austria, Belgium, Bulgaria, Croatia, Denmark, France, Germany, Greece, Hungary, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Spain
Stability in solutions   Injection   Stability in solutions : Trastuzumab deruxtecan     
Container Solvent Concentration Temperature Storage Duration References
Glass Water for Injection 20 mg/ml 2-8°C Protect from light
24 Hour
4717
Manufacturer's stability data

Not specified Glucose 5% ? mg/ml 2-8°C Protect from light
24 Hour
4717
Manufacturer's stability data

Not specified Glucose 5% ? mg/ml 20-25°C Protect from light
4 Hour
4717
Manufacturer's stability data


  Mentions Légales